Top compounds associated with response to MIF4GD


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA lapatinib CCLE pan-cancer AAC 0.13 0.005
mRNA methylstat CTRPv2 pan-cancer AAC 0.12 0.006
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.095 0.006
mRNA ouabain CTRPv2 pan-cancer AAC 0.1 0.007
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.13 0.007
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.16 0.007
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.007
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.12 0.008
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.091 0.009
Download CSV